Daily Trades

A lot of folks have written in to ask my if I think Recursion Pharmaceuticals (SYM: RXRX) is still a "BUY." Shares closed Friday at $11.93, a 39% gain from our recommended price of $8.57 a share.
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
Thanks to a new breakthrough… A new treatment for liver cancer was created in just 30 days.

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

A lot of folks have written in to ask my if I think Recursion Pharmaceuticals (SYM: RXRX) is still a "BUY." Shares closed Friday at $11.93, a 39% gain from our recommended price of $8.57 a share.
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
Thanks to a new breakthrough… A new treatment for liver cancer was created in just 30 days.

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.